<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id><journal-id journal-id-type="pmc">eid</journal-id><journal-title>Emerging Infectious Diseases</journal-title><issn pub-type="ppub">1080-6040</issn><issn pub-type="epub">1080-6059</issn><publisher><publisher-name>Centers for Disease Control</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">10756154</article-id><article-id pub-id-type="pmc">2640842</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Sin nombre virus (SNV) Ig isotype antibody response during acute and convalescent phases of hantavirus pulmonary syndrome.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bostik</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Winter</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ksiazek</surname><given-names>T. G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rollin</surname><given-names>P. E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Villinger</surname><given-names>F.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Zaki</surname><given-names>S. R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Peters</surname><given-names>C. J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ansari</surname><given-names>A. A.</given-names></name></contrib></contrib-group><aff>Emory University School of Medicine, Atlanta, GA 30322, USA.</aff><pub-date pub-type="ppub"><season>Mar-Apr</season><year>2000</year></pub-date><volume>6</volume><issue>2</issue><fpage>184</fpage><lpage>187</lpage><abstract><p>Serum samples from 22 hantavirus pulmonary syndrome (HPS) patients were tested for Sin Nombre virus (SNV)-reactive antibodies. In the acute phase of HPS, 100% and 67% of the samples tested positive for SNV-specific immunoglobulin (Ig) M and IgA, respectively. Among the virus-specific IgG antibodies, the most prevalent were IgG3 (in 97% of samples), followed by IgG1 (70%), IgG2 (30%), and IgG4 (3%).</p></abstract></article-meta></front></article>